Anders Lannergård

Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial

Torsten Sandberg, Gunilla Skoog, Anna Bornefalk‐Hermansson et al. · The Lancet · 2012 · 186 citations

Pharmacy, Pharmacotherapy, Antimicrobial Pharmacology +5

Correlations between serum amyloid A protein and C‐reactive protein in infectious diseases

Anders Lannergård, Anders Larsson, Peter Kragsbjerg et al. · Scandinavian Journal of Clinical and Laboratory Investigation · 2003 · 77 citations

Veterinary Medicine, Immunology, Infectious Diseases +15

Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational study

Isak Sundberg, Anders Lannergård, Mia Ramklint et al. · BMC Psychiatry · 2018 · 54 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

A Howe, Chaturaka Rodrigo, Evan B. Cunningham et al. · JHEP Reports · 2022 · 42 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +16

Prevalence of polymorphisms with significant resistance to NS5A inhibitors in treatment-naive patients with hepatitis C virus genotypes 1a and 3a in Sweden

I. Lindström, Midori Kjellin, Navaneethan Palanisamy et al. · Infectious Diseases · 2015 · 35 citations

Life Sciences, Infectious Diseases, Pharmacology +17